True Wealth Design’s Monte Rosa Therapeutics GLUE Stock Holding History

True Wealth Design’s Portfolio GLUE Stock Details GLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1K	Hold	84	–	–	﹤0.01%	1938
2026 Q2	$2.03K	Sell	84 -7	-8%	-$132	﹤0.01%	1686
2026 Q1	$1.5K	Sell	91 -20	-18%	-$382	﹤0.01%	1656
2025 Q4	$1.74K	Buy	111 +27	+32%	+$364	﹤0.01%	1503
2025 Q3	$623	Buy	84 +42	+100%	+$222	﹤0.01%	1936
2025 Q2	$190	Buy	42 +19	+83%	+$85	﹤0.01%	2090
2025 Q1	$107	Buy	+23	New	+$141	﹤0.01%	2168

Other funds holding GLUE

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Paladin Partners Hartland, Wisconsin $162M AUM 13.31% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

True Wealth Design's GLUE Position: Q3 2026 in Review

True Wealth Design held its Monte Rosa Therapeutics (GLUE) position steady in Q3 2026 at 84 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1938.

True Wealth Design first reported a position in GLUE in Q1 2025 and has held it in 7 quarters since. The position peaked at $2.03K in Q2 2026. 6 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.

True Wealth Design held 84 shares of Monte Rosa Therapeutics worth $1K as of Q3 2026.
True Wealth Design left its Monte Rosa Therapeutics share count unchanged in Q3 2026.
Monte Rosa Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1938 holding.
True Wealth Design first reported a position in Monte Rosa Therapeutics in Q1 2025 and has held it in 7 quarters since.
True Wealth Design's Monte Rosa Therapeutics position peaked at $2.03K in Q2 2026.
6 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.